CAB aims to protect 1.5 cr Hindus: Nalin Kumar Kateel

Jan 29: Karnataka Tourism Minister, CT Ravi came up in support of BJP leader Anurag Thakur, and made a controversial statement in the process.

Ravi recently took to Twitter to express his views on Thakur facing probe for allegedly making provocative statements. In his tweet, Ravi said that "anti-nationals should get bullet not biryani".

"Those attacking Union MoS @ianuragthakur for his statement against traitors are the ones who - opposed death to terrorirts Ajmal Kasab and Yakub Memon, supported tukde tukde gang, spread lies against CAA. Anti-nationals should get bullet not biryani," Ravi tweeted.

 @ianuragthakur

 #CAA

#IStandWithAnuragThakur

 January 28, 2020

Earlier, Thakur had allegedly made slogans like "Desh ke gaddaro ko, goli maaro saalo ko (shoot the traitors)" multiple times during a public meeting in Delhi. He had also faced a show-cause notice from the Electon Commission, asking a response from him on January 30.

Bengaluru, Feb 13: Veteran freedom fighter and advisor to the Karnataka Government in Education Reforms HS Doreswamy on Thursday has recommended Chief Minister BS Yediyurappa to make it mandatory for MLA and MLCs to adopt at least three govt Schools in their respective constituencies.

Mr Doreswamy appealed to the Chief Minister to implement the suggestion in the State budget for 2020-21 to be presented by him on March 5.

Addressing a press conference here, Mr Doreswamy, on the higher education sector, stressed the need to appoint highly qualified candidates for Vice Chancellor posts. There is no dearth of talent and eligibility in the State and authorities concerned must ensure that the right person is appointed by taking extreme care".

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.